Surfer Blood Guitarist Thomas Fekete Has Been Diagnosed With A Rare Form Of Cancer And His Bandmates Are Calling On Fans To Help Fund His Treatment.
The rocker revealed the news on crowdfunding site GoFundMe.com on Saturday (18Apr15), noting that he was diagnosed with the aggressive sarcoma a few months ago, and subsequently underwent a "major surgery" to remove a large tumour from his abdomen.
However, shortly before Fekete opened up to fans about his condition, he was told by his doctors that the cancer had spread to his lungs and spine.
Although he is beginning chemotherapy in the coming days, the musician has been forced to seek "an alternative treatment plan," one that his insurance will "only cover a portion of", since the cancer is so rare and little research has been done.
Now, Fekete and his bandmates are hoping their fans can help them raise a goal of $76,000 (£47,500) to cover the medical costs.
He writes, "Any bit of help would be massive for me, as I'm no longer able to tour and make a living, and my wonderful wife/best friend whom I just married in November will now be leaving work to help me throughout my treatment.
"Any extra funds collected when this is all said and done will be donated to further my doctor's alternative cancer research. I not only feel great, but I am in great spirits, and I know this will soon be over like a bad dream. Please take care of yourselves, enjoy every single day. Life is beautiful. Love and light always."
His bandmates have also released a statement of support for their friend as he battles the disease. It reads: "Thomas has been playing guitar in Surfer Blood for nearly six years, but since December has been sidelined by treatment for cancer. We miss him every day on the road but we know he is incredibly strong and we have faith in him, and in his doctors. We hope you can help with a donation of any size, and help spread the word by sharing on social media."
Fekete has pulled out of Surfer Blood's current tour in support of their new album, 1000 Palms, which is set for release next month (May15).